Global Head of Biotechnology Research & Senior Pharma and Biotech Analyst
Michael Yee is the Global Head of Biotechnology Research at UBS & Senior Pharma and Biotech Analyst. Prior to joining UBS he was a Managing Director and Senior Biotechnology Analyst at Jefferies LLC since 2017 and he has been working in Healthcare Equity Research on Wall Street for over 25 years including over 20 years covering the Biotechnology sector. He was previously a Managing Director covering Biotechnology at RBC Capital Markets. For almost two decades, he is a top-ranked analyst in the Institutional Investor /Extel annual poll across both Large-Cap biotechnology and Small/Mid Cap biotechnology categories. Michael Yee is also a frequent TV guest on top rated financial news and media outlets including CNBC, WSJ, FT, and Reuters. Michael received a BA in Molecular Cell Biology from the University of California, Berkeley, and an MBA from UC Berkeley’s Haas School of Business